14-70329183-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_016468.7(COX16):c.195G>A(p.Ser65=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000661 in 1,588,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000039 ( 0 hom. )
Consequence
COX16
NM_016468.7 synonymous
NM_016468.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.547
Genes affected
COX16 (HGNC:20213): (cytochrome c oxidase assembly factor COX16) Involved in mitochondrial cytochrome c oxidase assembly. Is integral component of mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 14-70329183-C-T is Benign according to our data. Variant chr14-70329183-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3076444.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.547 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX16 | NM_016468.7 | c.195G>A | p.Ser65= | synonymous_variant | 3/4 | ENST00000389912.7 | NP_057552.1 | |
SYNJ2BP-COX16 | NM_001202549.2 | c.351G>A | p.Ser117= | synonymous_variant | 4/5 | NP_001189478.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX16 | ENST00000389912.7 | c.195G>A | p.Ser65= | synonymous_variant | 3/4 | 1 | NM_016468.7 | ENSP00000374562 | P1 | |
ENST00000655620.1 | n.713-13489C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000324 AC: 49AN: 151046Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
49
AN:
151046
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000974 AC: 24AN: 246380Hom.: 0 AF XY: 0.0000375 AC XY: 5AN XY: 133424
GnomAD3 exomes
AF:
AC:
24
AN:
246380
Hom.:
AF XY:
AC XY:
5
AN XY:
133424
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000389 AC: 56AN: 1437934Hom.: 0 Cov.: 30 AF XY: 0.0000266 AC XY: 19AN XY: 715058
GnomAD4 exome
AF:
AC:
56
AN:
1437934
Hom.:
Cov.:
30
AF XY:
AC XY:
19
AN XY:
715058
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000324 AC: 49AN: 151046Hom.: 0 Cov.: 31 AF XY: 0.000516 AC XY: 38AN XY: 73714
GnomAD4 genome
AF:
AC:
49
AN:
151046
Hom.:
Cov.:
31
AF XY:
AC XY:
38
AN XY:
73714
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3464
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at